ALL KEYWORDSNonalcoholic Steatohepatitis (NASH)Related SpecialistsShowing 3 of 26Wajahat MehalMD, PhD, DPhilVikas GuptaMD, PhDMichael SchilskyMDMore Related SpecialistsRelated Clinical TrialsShowing 2 of 4A Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients With (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Liver Fibrosis (NATiV3)LiverGender:All GendersAge:18 years and olderPathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Youth with ObesityDiabetesLiverEndocrine SystemObesity & Weight ManagementGender:All GendersAge:12 years - 22 yearsMore Related Clinical TrialsRelated NewsFamily HealthPatient StoriesRelated DepartmentsShowing 3 of 24Smilow Interventional Oncology ProgramInternal MedicineRadiology & Biomedical ImagingMore Related Departments
